Literature DB >> 12897555

Surgical excision of acoustic neuroma: patient outcome and provider caseload.

Fred G Barker1, Bob S Carter, Robert G Ojemann, Robert W Jyung, Dennis S Poe, Michael J McKenna.   

Abstract

OBJECTIVES/HYPOTHESIS: For many complex surgical procedures, larger hospital or surgeon caseload is associated with better patient outcome. We examined the volume-outcome relationship for surgical excision of acoustic neuromas. STUDY
DESIGN: Retrospective cohort study.
METHODS: The Nationwide Inpatient Sample (1996 to 2000) was used. Multivariate regression analyses were adjusted for age, sex, race, payer, geographic region, procedure timing, admission type and source, medical comorbidities, and neurofibromatosis status.
RESULTS: At 265 hospitals, 2643 operations were performed by 352 identified primary surgeons. Outcome was measured on a four-level scale at hospital discharge: death (0.5%) and discharge to long-term care (1.2%), to short-term rehabilitation (4.4%), and directly to home (94%). Outcomes were significantly better after surgery at higher-volume hospitals (OR 0.47 for fivefold-larger caseload, P <.001) or by higher-volume surgeons (OR 0.46, P <.001). Of patients who had surgery at lowest-volume-quartile hospitals, 12.3% were not discharged directly home, compared with 4.1% at highest-volume-quartile hospitals. There was a trend toward lower mortality for higher-volume hospitals (P =.1) and surgeons (P =.06). Of patients who had surgery at lowest-caseload-quartile hospitals, 1.1% died, compared with 0.6% at highest-volume-quartile hospitals. Postoperative complications (including neurological complications, mechanical ventilation, facial palsy, and transfusion) were less likely with high-volume hospitals and surgeons. Length of stay was significantly shorter with high-volume hospitals (P =.01) and surgeons (P =.009). Hospital charges were lower for high-volume hospitals (by 6% [P =.006]) and surgeons (by 6% [P =.09]).
CONCLUSION: For acoustic neuroma excision, higher-volume hospitals and surgeons provided superior short-term outcomes with shorter lengths of stay and lower charges.

Entities:  

Mesh:

Year:  2003        PMID: 12897555     DOI: 10.1097/00005537-200308000-00013

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  20 in total

1.  A case of high-grade undifferentiated sarcoma after surgical resection and stereotactic radiosurgery of a vestibular schwannoma.

Authors:  Tong Yang; Jason Rockhill; Donald E Born; Laligam N Sekhar
Journal:  Skull Base       Date:  2010-05

2.  Morbidity and mortality following acoustic neuroma excision in the United States: analysis of racial disparities during a decade in the radiosurgery era.

Authors:  Shearwood McClelland; Hongfei Guo; Kolawole S Okuyemi
Journal:  Neuro Oncol       Date:  2011-08-19       Impact factor: 12.300

3.  Trends in intracranial meningioma surgery and outcome: a Nationwide Inpatient Sample database analysis from 2001 to 2010.

Authors:  Sudheer Ambekar; Mayur Sharma; Venkatesh S Madhugiri; Anil Nanda
Journal:  J Neurooncol       Date:  2013-07-13       Impact factor: 4.130

4.  The effect of transfer and hospital volume in subarachnoid hemorrhage patients.

Authors:  Miriam Nuño; Chirag G Patil; Patrick Lyden; Doniel Drazin
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

Review 5.  Microsurgical resection of vestibular schwannomas: complication avoidance.

Authors:  Shervin Rahimpour; Allan H Friedman; Takanori Fukushima; Ali R Zomorodi
Journal:  J Neurooncol       Date:  2016-09-20       Impact factor: 4.130

6.  A Cross-sectional Survey of the North American Skull Base Society: Current Practice Patterns of Vestibular Schwannoma Evaluation and Management in North America.

Authors:  Matthew L Carlson; Jamie J Van Gompel; R Mark Wiet; Nicole M Tombers; Anand K Devaiah; Devyani Lal; Jacques J Morcos; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-03

7.  Does where you live influence how your vestibular schwannoma is managed? Examining geographical differences in vestibular schwannoma treatment across the United States.

Authors:  Matthew L Carlson; Amy E Glasgow; Brandon R Grossardt; Elizabeth B Habermann; Michael J Link
Journal:  J Neurooncol       Date:  2016-06-22       Impact factor: 4.130

Review 8.  Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authors:  Scott R Plotkin; Chris Halpin; Jaishri O Blakeley; William H Slattery; D Bradley Welling; Susan M Chang; Jay S Loeffler; Gordon J Harris; A Gregory Sorensen; Michael J McKenna; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

Review 9.  Racial, ethnic and socioeconomic disparities in the treatment of brain tumors.

Authors:  William T Curry; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

10.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.